CMA clears Welltower care-home deals with remedies

CMA clears Welltower care-home deals with remedies

UK competition regulators cleared Welltower care-home acquisitions with structural remedies. The package uses targeted divestments and operator changes after the CMA identified potential competition concerns in local care-home markets.


The Competition and Markets Authority has accepted remedies allowing Welltower to avoid an in-depth Phase 2 investigation into its acquisition of UK care-home portfolios, with divestments and changes of operator intended to address local competition concerns.

The decision follows a Phase 1 investigation covering completed acquisitions involving homes managed by Barchester Healthcare, HC-One, Aria Care including Asprey, and Danforth Care.

Welltower acquired real-estate interests in the portfolios in 2025, creating a structure in which ownership of care-home property and day-to-day operation could sit with different organisations.

The CMA concluded at Phase 1 that the transactions had resulted, or could be expected to result, in a substantial lessening of competition in a number of local areas unless acceptable undertakings were offered.

Welltower and Apex subsequently proposed remedies rather than proceed to a full Phase 2 inquiry. The regulator consulted on undertakings involving divestment of certain freehold or leasehold interests, transfers of operating businesses, and changes of operator at selected homes.

The case demonstrates the highly local nature of competition analysis in adult social care. A transaction can encompass hundreds of sites while concerns arise only in individual towns or catchment areas where residents and families have comparatively few realistic alternatives.

That produces a different remedy calculation from a national market. A regulator may be able to address concentration through selected asset disposals or operator changes rather than requiring a buyer to unwind an entire transaction.

Care homes also create a more complicated ownership structure than many conventional acquisitions. Property ownership and responsibility for providing care can rest with different businesses, requiring competition analysis to consider both the economic influence of the landlord and the market position of individual operators.

The Welltower transactions brought that distinction into focus. The US-listed healthcare property investor acquired the real-estate interests, while operating arrangements involved separate care providers.

Institutional investment in UK care-home property has continued as long-term demographic demand attracts capital. Operators, however, face a separate set of pressures including labour costs, regulation, occupancy, local-authority funding, energy costs, and the operational requirements of providing regulated care.

Those conditions make local competitive choice especially important. Residents cannot always substitute a home many miles away, while specialist nursing requirements, proximity to family, available beds, and the urgency of a placement can reduce the practical number of alternatives.

Investors building portfolios of local-service assets therefore need competition analysis at a more granular level than national market share. Concentration may only become problematic around particular assets even where the combined business remains fragmented across the country as a whole.

Remedies can also create significant work after an acquisition has completed. Asset sales need suitable purchasers, operating transfers may require regulatory and contractual approvals, and any change in provider has to preserve continuity of care for residents.

The Welltower acquisitions had already completed before the merger investigation reached the remedies stage, increasing the importance of measures capable of separating or reallocating selected assets without destabilising the remainder of the portfolio.

The undertakings allow the transactions to avoid the additional time and uncertainty associated with a Phase 2 investigation, although implementation of the required disposals and operator changes remains part of the regulatory outcome.

The case reinforces the scrutiny that can apply to large portfolios of locally delivered services even where the acquiring business operates principally as a property investor rather than the direct provider of the underlying service.

It also provides a reminder that competition risk can arise from the geography and operating structure of individual assets, rather than the headline national scale of a transaction alone.

—



  • Avon Technologies lifts outlook and growth targets

    Avon Technologies lifts outlook and growth targets

    Avon Technologies has raised expectations and set new growth targets. The protective equipment group expects 2026 performance above market forecasts and is targeting revenue above $600m over five years.


  • CMA formally launches Healthcare Ireland merger inquiry

    CMA formally launches Healthcare Ireland merger inquiry

    The CMA has formally launched its Healthcare Ireland merger inquiry. Its Phase 1 review of the completed Hutchinson Homes acquisition now carries a statutory decision deadline of 3 December.


  • TPFG takes 25% stake in Enteka AI

    TPFG takes 25% stake in Enteka AI

    TPFG has bought a 25% stake in Enteka AI today. The £900,000 investment follows deployment across more than 210 offices and is tied to a three-year preferred-provider agreement.